Ishare Nq Biotch ETF (IBB) 255.48 $IBB
Jim Cramer -- Biotech Stocks' Window of Opportunity
at The Street - Fri Mar 25, 1:30PM CDT
Jim Cramer says that biotech stocks could have a window of opportunity to rally as Valeant rebounds and as politicians lay off the sector.
VRX: 31.09 (-2.34), IBB: 255.48 (+1.22)
Trader's Notebook: Biotech Has Momentum
at The Street - Wed Mar 23, 8:00AM CDT
Also, oil data surprise and E-mini bullishness wanes.
XBI: 50.05 (+0.18), IBB: 255.48 (+1.22)
Jim Cramer -- Bernie Sanders Dropout Could Rally Biotech Stocks
at The Street - Tue Mar 22, 11:57AM CDT
If Hillary Clinton can knock Bernie Sanders from the Democratic presidential race, it could spur a rally in the biotech sector, says Jim Cramer.
VRX: 31.09 (-2.34), AMGN: 149.24 (+0.48), IBB: 255.48 (+1.22)
Trader's Notebook: Reduced Volume Alert
at The Street - Tue Mar 22, 8:00AM CDT
Avoid over-trading at all costs.
IBB: 255.48 (+1.22)
After Yesterday's Rally of 1.95% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Mar 21, 12:14PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $250.26 to a high of $257.66. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $255.50 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 255.48 (+1.22)
Better Buy: Intuitive Surgical, Inc. vs. Medtronic PLC
Cory Renauer, The Motley Fool - Motley Fool - Mon Mar 21, 8:01AM CDT
The medical-device industry is expected to grow right along with average life spans and incomes among developed nations. Trying to ride this trend by investing in most drugmakers has been disastrous recently. The Nasdaq Biotechnology Index ,...
ISRG: 583.31 (-3.02), MDT: 73.97 (-0.53), XPH: 39.39 (-0.19), IBB: 255.48 (+1.22), IHI: 119.22 (-0.51)
3 Biotech Stocks to Buy in March
Cheryl Swanson, Kristine Harjes, and Brian Feroldi, The Motley Fool - Motley Fool - Fri Mar 18, 3:39PM CDT
Looking for stocks to buy? It's time to get in some shots before the weather warms up. Flickr: Creative Commons March--as the saying goes--comes in like a lion and goes out like a lamb. And biotechs may be about to do the same, although it's...
PTLA: 20.27 (-8.35), IBB: 255.48 (+1.22), IONS: 41.62 (+1.82), REGN: 370.80 (+5.42)
3 Biotech Stocks to Buy on Sale
Brian Feroldi, Sean Williams, and Cheryl Swanson, The Motley Fool - Motley Fool - Fri Mar 18, 7:22AM CDT
Image Source TBIT via pixabay The broad S&P 500 has rallied over the last few weeks, and it has largely recovered from the beating that it took early in the year. The biotech sector, however, hasn't fared quite as well. Many biotech stocks...
AGN: 279.32 (-1.99), GERN: 2.86 (+0.08), PFE: 30.08 (-0.11), IBB: 255.48 (+1.22), CHRS: 19.41 (+0.30)
Rev's Forum: Be Careful About Being Too Negative Ahead of the Fed
at The Street - Wed Mar 16, 6:49AM CDT
The market still loves to love the Fed.
VRX: 31.09 (-2.34), IBB: 255.48 (+1.22)
The Trader Daily: Valeant's Crash Scatters Debris
at The Street - Wed Mar 16, 6:00AM CDT
Bad news was widespread amid biotech and related sectors.
PPH: 57.22 (-0.23), VRX: 31.09 (-2.34), XBI: 50.05 (+0.18), IBB: 255.48 (+1.22)
Why Exelixis' Stock Dropped 10% on Tuesday
George Budwell, The Motley Fool - Motley Fool - Wed Mar 09, 9:30AM CST
What: Shares of Exelixis , a small-cap biopharma focusing on the development of cancer treatments, fell by 10.42% yesterday on higher-than-normal volume. The good news is that this double-digit decline doesn't appear to be linked to a...
IBB: 255.48 (+1.22), EXEL: 4.04 (+0.07)
Why It Makes Sense To 'Bet The Farm' With A Portion Of Your Portfolio
William Koldus, CFA, CAIA - at Seeking Alpha - Wed Mar 09, 9:28AM CST
KMI: 18.09 (+0.34), USO: 10.06 (-0.05), CNX: 10.94 (+0.50), UNG: 6.40 (+0.10), FCX: 10.11 (+0.36), IBB: 255.48 (+1.22), CLD: 2.02 (+0.02), UNT: 9.32 (+0.05), BTU: 2.56 (+0.16), SPY: 203.12 (-0.09), TCK: 7.36 (+0.07), CHK: 4.25 (+0.12), SUNE: 1.21 (-0.06), X: 15.78 (+0.94), SWN: 7.38 (+0.03)
3 Reasons Jazz Pharmaceuticals Stock Could Rise in 2016
Cory Renauer, The Motley Fool - Motley Fool - Tue Mar 08, 12:20PM CST
Over the past 12 months, Jazz Pharmaceuticals stock has fallen along with the Nasdaq Biotechnology ETF . Public outcry over rising prescription drug prices is largely to blame for the losses seen in the biotechnology index (and across the...
JAZZ: 118.59 (-2.52), IBB: 255.48 (+1.22)
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 2.52% Rise
Comtex SmarTrend(R) - Mon Mar 07, 5:11PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $260.92 to a high of $272.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $269.79 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 255.48 (+1.22)
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.52% Yesterday
Comtex SmarTrend(R) - Mon Mar 07, 5:11PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $260.92 to a high of $272.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $269.79 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 255.48 (+1.22)
So Many Topics, So Few Columns
at The Street - Sat Mar 05, 11:00AM CST
In response to reader input, here's what to look for from me.
XBI: 50.05 (+0.18), IBB: 255.48 (+1.22), BAC: 13.68 (+0.06), GDX: 19.46 (+0.43)
5 Revenant Sectors Echo Leo's Oscar-Winning Performance
Zacks Equity Research - Zacks Investment Research - Fri Mar 04, 2:30PM CST
Like the determined Hugh Glass, these sectors stood up to escape a bear market following massive sell-offs at the start of the year and register solid gains over the past month.
AMZN: 582.95 (+13.32), UNH: 128.59 (-1.20), XLY: 77.55 (+0.10), DIS: 97.22 (+0.39), IBB: 255.48 (+1.22), XOM: 83.98 (+0.23), XLV: 67.39 (-0.03), JPM: 59.48 (-0.46), MRK: 53.07 (-0.01), DD: 63.95 (+0.20), XLFS: 28.29 (-0.56), BRK.B: 140.11 (-0.85), CVX: 94.85 (+1.26), DOW: 51.32 (+0.14)
Trader's Notebook: Is It Biotech's Turn to Outperform?
at The Street - Fri Mar 04, 8:00AM CST
The biotechnology sector has lagged horribly.
VALE: 4.04 (+0.20), XBI: 50.05 (+0.18), IBB: 255.48 (+1.22), TWI: 5.42 (+0.35)
Small Caps And Biotech Remain Weak Links Despite The Recent Rebound
Michael Harris - Seeking Alpha - Thu Mar 03, 1:40PM CST
In an article on June 20, 2015, I concluded that the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB ) and iShares Russell 2000 ETF (NYSEARCA: IWM ) were bubble markets, after analyzing their top 20 holding. Due to the correction that followed, IBB...
IBB: 255.48 (+1.22), IWM: 107.20 (+0.32)
Jim Cramer -- Biotech Stocks' Window of Opportunity
at The Street - Fri Mar 25, 1:30PM CDT
Jim Cramer says that biotech stocks could have a window of opportunity to rally as Valeant rebounds and as politicians lay off the sector.
VRX: 31.09 (-2.34), IBB: 255.48 (+1.22)
Trader's Notebook: Biotech Has Momentum
at The Street - Wed Mar 23, 8:00AM CDT
Also, oil data surprise and E-mini bullishness wanes.
XBI: 50.05 (+0.18), IBB: 255.48 (+1.22)
Jim Cramer -- Bernie Sanders Dropout Could Rally Biotech Stocks
at The Street - Tue Mar 22, 11:57AM CDT
If Hillary Clinton can knock Bernie Sanders from the Democratic presidential race, it could spur a rally in the biotech sector, says Jim Cramer.
VRX: 31.09 (-2.34), AMGN: 149.24 (+0.48), IBB: 255.48 (+1.22)
Trader's Notebook: Reduced Volume Alert
at The Street - Tue Mar 22, 8:00AM CDT
Avoid over-trading at all costs.
IBB: 255.48 (+1.22)
After Yesterday's Rally of 1.95% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Mar 21, 12:14PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $250.26 to a high of $257.66. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $255.50 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 255.48 (+1.22)
Better Buy: Intuitive Surgical, Inc. vs. Medtronic PLC
Cory Renauer, The Motley Fool - Motley Fool - Mon Mar 21, 8:01AM CDT
The medical-device industry is expected to grow right along with average life spans and incomes among developed nations. Trying to ride this trend by investing in most drugmakers has been disastrous recently. The Nasdaq Biotechnology Index ,...
ISRG: 583.31 (-3.02), MDT: 73.97 (-0.53), XPH: 39.39 (-0.19), IBB: 255.48 (+1.22), IHI: 119.22 (-0.51)
3 Biotech Stocks to Buy in March
Cheryl Swanson, Kristine Harjes, and Brian Feroldi, The Motley Fool - Motley Fool - Fri Mar 18, 3:39PM CDT
Looking for stocks to buy? It's time to get in some shots before the weather warms up. Flickr: Creative Commons March--as the saying goes--comes in like a lion and goes out like a lamb. And biotechs may be about to do the same, although it's...
PTLA: 20.27 (-8.35), IBB: 255.48 (+1.22), IONS: 41.62 (+1.82), REGN: 370.80 (+5.42)
3 Biotech Stocks to Buy on Sale
Brian Feroldi, Sean Williams, and Cheryl Swanson, The Motley Fool - Motley Fool - Fri Mar 18, 7:22AM CDT
Image Source TBIT via pixabay The broad S&P 500 has rallied over the last few weeks, and it has largely recovered from the beating that it took early in the year. The biotech sector, however, hasn't fared quite as well. Many biotech stocks...
AGN: 279.32 (-1.99), GERN: 2.86 (+0.08), PFE: 30.08 (-0.11), IBB: 255.48 (+1.22), CHRS: 19.41 (+0.30)
Rev's Forum: Be Careful About Being Too Negative Ahead of the Fed
at The Street - Wed Mar 16, 6:49AM CDT
The market still loves to love the Fed.
VRX: 31.09 (-2.34), IBB: 255.48 (+1.22)
The Trader Daily: Valeant's Crash Scatters Debris
at The Street - Wed Mar 16, 6:00AM CDT
Bad news was widespread amid biotech and related sectors.
PPH: 57.22 (-0.23), VRX: 31.09 (-2.34), XBI: 50.05 (+0.18), IBB: 255.48 (+1.22)
Why Exelixis' Stock Dropped 10% on Tuesday
George Budwell, The Motley Fool - Motley Fool - Wed Mar 09, 9:30AM CST
What: Shares of Exelixis , a small-cap biopharma focusing on the development of cancer treatments, fell by 10.42% yesterday on higher-than-normal volume. The good news is that this double-digit decline doesn't appear to be linked to a...
IBB: 255.48 (+1.22), EXEL: 4.04 (+0.07)
Why It Makes Sense To 'Bet The Farm' With A Portion Of Your Portfolio
William Koldus, CFA, CAIA - at Seeking Alpha - Wed Mar 09, 9:28AM CST
KMI: 18.09 (+0.34), USO: 10.06 (-0.05), CNX: 10.94 (+0.50), UNG: 6.40 (+0.10), FCX: 10.11 (+0.36), IBB: 255.48 (+1.22), CLD: 2.02 (+0.02), UNT: 9.32 (+0.05), BTU: 2.56 (+0.16), SPY: 203.12 (-0.09), TCK: 7.36 (+0.07), CHK: 4.25 (+0.12), SUNE: 1.21 (-0.06), X: 15.78 (+0.94), SWN: 7.38 (+0.03)
3 Reasons Jazz Pharmaceuticals Stock Could Rise in 2016
Cory Renauer, The Motley Fool - Motley Fool - Tue Mar 08, 12:20PM CST
Over the past 12 months, Jazz Pharmaceuticals stock has fallen along with the Nasdaq Biotechnology ETF . Public outcry over rising prescription drug prices is largely to blame for the losses seen in the biotechnology index (and across the...
JAZZ: 118.59 (-2.52), IBB: 255.48 (+1.22)
Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 2.52% Rise
Comtex SmarTrend(R) - Mon Mar 07, 5:11PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $260.92 to a high of $272.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $269.79 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 255.48 (+1.22)
Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.52% Yesterday
Comtex SmarTrend(R) - Mon Mar 07, 5:11PM CST
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $260.92 to a high of $272.07. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $269.79 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 255.48 (+1.22)
So Many Topics, So Few Columns
at The Street - Sat Mar 05, 11:00AM CST
In response to reader input, here's what to look for from me.
XBI: 50.05 (+0.18), IBB: 255.48 (+1.22), BAC: 13.68 (+0.06), GDX: 19.46 (+0.43)
5 Revenant Sectors Echo Leo's Oscar-Winning Performance
Zacks Equity Research - Zacks Investment Research - Fri Mar 04, 2:30PM CST
Like the determined Hugh Glass, these sectors stood up to escape a bear market following massive sell-offs at the start of the year and register solid gains over the past month.
AMZN: 582.95 (+13.32), UNH: 128.59 (-1.20), XLY: 77.55 (+0.10), DIS: 97.22 (+0.39), IBB: 255.48 (+1.22), XOM: 83.98 (+0.23), XLV: 67.39 (-0.03), JPM: 59.48 (-0.46), MRK: 53.07 (-0.01), DD: 63.95 (+0.20), XLFS: 28.29 (-0.56), BRK.B: 140.11 (-0.85), CVX: 94.85 (+1.26), DOW: 51.32 (+0.14)
Trader's Notebook: Is It Biotech's Turn to Outperform?
at The Street - Fri Mar 04, 8:00AM CST
The biotechnology sector has lagged horribly.
VALE: 4.04 (+0.20), XBI: 50.05 (+0.18), IBB: 255.48 (+1.22), TWI: 5.42 (+0.35)
Small Caps And Biotech Remain Weak Links Despite The Recent Rebound
Michael Harris - Seeking Alpha - Thu Mar 03, 1:40PM CST
In an article on June 20, 2015, I concluded that the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB ) and iShares Russell 2000 ETF (NYSEARCA: IWM ) were bubble markets, after analyzing their top 20 holding. Due to the correction that followed, IBB...
IBB: 255.48 (+1.22), IWM: 107.20 (+0.32)
